CLINICAL_TRIALS trial_result · 2021-08-13

Clinical Trial Update: The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms [Phase 3]

Phase 3 trial evaluating amantadine for prevention of progression and treatment of COVID-19 symptoms; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Independent Public Clinical Hospital No. 4 in Lublin | Conditions: COVID-19, SARS-CoV-2 | Phase 3 | Status: UNKNOWN